| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Overall positivity rates in urine drug tests in the transportation/warehousing industry increased 4.4% in 2020 versus 5.5% in 2021 – a relative 25% increase year over year – according to data compiled by medical lab Quest Diagnostics. Almost 130,000 truck drivers have found themselves in the Drug and Alcohol Clearinghouse as of June 1. Nearly 97,000 are still in prohibited status, and 72,000 of those haven’t even started the return to duty process.
Rite Aid is collaborating with Quest Diagnostics to provide access to COVID molecular testing to help its customers detect and prevent the spread of the virus. Quest is a provider of diagnostic information services and COVID testing. The company has performed more than 69 million COVID-19 molecular tests since March 2020.
Dr. Michael Racke is the Medical Director at Quest Advanced Neurology, which is extending the options for neurologic diagnoses by looking for biomarkers in blood tests. Michael explains, "And now, we're very much involved in developing plasma-based biomarkers to help diagnose Alzheimer's disease. Alzheimer's disease was a disorder that was initially diagnosed pathologically. You had to find the plaque and tangles in the brain at autopsy.
Quest Diagnostics said Wednesday that its proprietary monkeypox virus test is now available across the U.S., and within a month, it will be able to process samples using the Centers for Disease Control and Prevention’s orthopoxvirus test.
Alzheimer’s Disease prevention and identification may become more achievable with emerging solutions, according to Michael Racke, MD, Medical Director of Neurology at Quest Diagnostics. On a recent Healthcare Strategies episode, Racke shared about a new test called AD Detect which uses a blood sample to identify the presence of Alzheimer’s Disease early in the disease’s progress.